Stock

GTx, Inc. (GTXI) Stock Rating Lowered by Zacks Investment Research

According to Zacks, “GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical …

4
Like
Save